Blockade of BRAF in the BRAFV600E melanoma lines resulted in a drop in activating phosphorylations throughout the MAP Kinase pathway, including the transcription factor ELK1 and downstream kinases p90RSK and MSK1. The gene discussed is RPS6KA5; the disease is melanoma.